Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 93

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 93
---
 Aviv University and Universitat de Barcelona.

Matti Munk, was appointed a director on February 18, 2021. Mr. Munk has 20 years of experience in international investment and banking; engaging in international activities, economics, financing, management. Since 2020, he has served as director and Chief Economist at Comforte Capital. Amazon Aggregator; since 2016, he serves as CEO of Western Wall Street, leading corporate finance and Capital Raises for Israeli Corporations and UK real estate projects and performing oversight/financial reporting on behalf of investors in local the corporations. Between 2008 and 2016, Mr. Munk served as manager in International Private Banking. Mercantile Discount Bank. Mr. Munk was responsible for overseeing department and commercial loans division and establishing and maintaining internal and external relationships with Institutional Market and Family offices. Mr. Munk received MBA in Finance in 2011 from University of Liverpool, UK and BA in Economic and Finance in 1997 from Bar-Ilan University.

Mordechai Jacobson, 55, was appointed a director of the Company on February 18, 2021. Since 2022, Mr. Jacobson serves as CFO in Beesense Sensors Ltd, an international company, providing extensive work with banks and financing companies, including treasury and cash flow management. From 2014 to 2022, he worked as CEO in ESMD Call Centers S.R.O, Czech Republic, providing business development and management of call centers selling insurance and financial products in EU and Asia. Mr. Jacobson received MBA in 2023, obtaining executive MBA program from Tel Aviv University and BA in Economics in 1996 from Tel Aviv University.

The above-listed officers and directors will serve until the next annual meeting of the stockholders or until their death, resignation, retirement, removal, or disqualification, or until their successors have been duly elected and qualified. Vacancies in the existing Board of Directors are filled by majority vote of the remaining Directors. Officers serve at the will of the Board of Directors.

Board Committees

The Company has not established any committees. The entire Board participates in the nomination and audit oversight processes and considers executive and director compensation. Given the size of the Company and its stage of development, the entire Board is involved in such decision-making processes. Thus, there is a potential conflict of interest in that our directors and officers have the authority to determine issues concerning management compensation, nominations, and audit issues that may affect management decisions. We are not aware